Are peptides legal in Spain?
The short answer
In Spain medicines have to be evaluated and authorised before they are marketed, and authorised medicines must move through the legal channels and be dispensed by authorised pharmacies. GLP-1 receptor agonists, among them semaglutide and tirzepatide, are prescription medicines, and prescription medicines cannot be marketed over the internet in Spain. In sport, the national prohibited list bans peptide hormones, growth hormone releasing factors and non approved substances such as the peptide BPC-157 at all times, in and out of competition.
Status by category
| Category | Status |
|---|---|
| Approved peptide medicines | Prescription only |
| Research peptides | Unclear |
| Compounded preparations | Restricted |
| Cosmetics | Restricted |
| Food supplements | Unclear |
| Personal import | Restricted |
| Sport and anti-doping | Prohibited |
Approved peptide medicines Prescription only
Medicines must be evaluated and authorised before being marketed, and authorised medicines have to move through the legal channels and be dispensed by authorised pharmacies or pharmacy services. GLP-1 receptor agonists are prescription medicines for the treatment of diseases such as diabetes and obesity. Prescription medicines cannot be marketed through the internet in Spain, and patients are told to consult a doctor and not to buy these medicines without a prescription or outside pharmacies. [1][2][7]
Research peptides Unclear
No specific official rule found.
Compounded preparations Restricted
Spanish law allows pharmacy preparation in two forms: the fórmula magistral, a medicine for an individual patient prepared by the pharmacist to fulfil a detailed medical prescription, and the preparado oficinal, listed and described in the Formulario Nacional. Any such preparation may only be made by a pharmacist or by another qualified person under direct pharmacist control, following the rules of correct preparation and quality control. The sources checked do not name any peptide as an authorised compounding substance. [5]
Cosmetics Restricted
AEMPS sets out the Spanish legal framework for cosmetic products as a list of texts that includes Regulation (EC) No 1223/2009 and Real Decreto 85/2018. Ingredients are restricted by the annexes of that Regulation: substances listed in Annex II cannot be used, and those in Annex III only at the concentrations and conditions set there. Before a cosmetic product is placed on the market the responsible person must have it submitted to a safety assessment and a safety report drawn up. The sources checked do not name any individual peptide. [6]
Food supplements Unclear
No specific official rule found.
Personal import Restricted
Travellers may carry their personal medication, and a prescription or a medical report may be required both on entry to and exit from Spain. The quantity must match the prescribed treatment, must not suggest illicit trafficking, and should not exceed what is needed for three months of treatment, with higher amounts accepted only exceptionally and when duly justified. [3]
Sport and anti-doping Prohibited
The prohibited list approved by the Presidency of the Consejo Superior de Deportes and published in the BOE applies to doping controls in official national competitions and to licensed athletes outside them. Class S2 covers peptide hormones, growth factors, related substances and mimetics, prohibited at all times in and out of competition, together with substances of similar chemical structure or similar biological effects. Class S0 also prohibits at all times any pharmacological substance not covered elsewhere in the list and not currently approved by a governmental health regulatory authority for human therapeutic use. [4]
Peptide by peptide
| Peptide | Status | Details |
|---|---|---|
| semaglutide | Prescription only | Named by AEMPS as a GLP-1 receptor agonist, a class described as prescription medicines that cannot be marketed over the internet in Spain. [1] |
| tirzepatide | Prescription only | Named by AEMPS as a GLP-1 receptor agonist, a class described as prescription medicines that cannot be marketed over the internet in Spain. [1] |
| BPC-157 | Restricted | Named in class S0 of the national prohibited list in sport, so it is prohibited at all times, in and out of competition. [4] |
| CJC-1295 | Restricted | Named as a GHRH analogue in class S2.2.4 of the national prohibited list in sport, prohibited at all times. [4] |
| ipamorelin | Restricted | Named as a growth hormone secretagogue in class S2.2.4 of the national prohibited list in sport, prohibited at all times. [4] |
| AOD-9604 | Restricted | Named as a growth hormone fragment in class S2.2.3 of the national prohibited list in sport, prohibited at all times. [4] |
| sermorelin | Restricted | Named as a GHRH analogue in class S2.2.4 of the national prohibited list in sport, prohibited at all times. [4] |
| tesamorelin | Restricted | Named as a GHRH analogue in class S2.2.4 of the national prohibited list in sport, prohibited at all times. [4] |
Change history
- Real Decreto 85/2018 regulating cosmetic products, which adds the national provisions needed to align Spanish rules with the European cosmetics Regulation. [6]
- Previous list of substances and methods prohibited in sport, approved by Resolution of the Presidency of the Consejo Superior de Deportes; later repealed. [4]
- AEMPS information note (reference AEMPS, 26/2025) reporting the EMA and HMA warning on the sharp rise of illegal medicines marketed as GLP-1 receptor agonists, including semaglutide and tirzepatide, and restating that prescription medicines cannot be marketed over the internet in Spain. [1]
- New list of substances and methods prohibited in sport approved by Resolution of the Presidency of the Consejo Superior de Deportes (published in the BOE on 9 December 2025); the 27 November 2024 list is repealed. [4]
- The 2026 prohibited list enters into force, with class S0 naming the peptide BPC-157 and class S2 covering peptide hormones, growth factors and mimetics. [4]
- Latest update of the AEMPS page on medicines for the treatment of travellers, which sets the prescription or medical report requirement and the three month quantity limit for personal medication. [3]
Official sources
- La EMA y HMA advierten del aumento de medicamentos ilegales comercializados como análogos de GLP-1, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
- Medicamentos ilegales, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
- Medicamentos destinados al tratamiento de los viajeros (comercio exterior), Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
- Resolución de 2 de diciembre de 2025, de la Presidencia del Consejo Superior de Deportes, por la que se aprueba la lista de sustancias y métodos prohibidos en el deporte (BOE-A-2025-25042), Boletín Oficial del Estado / Consejo Superior de Deportes (CELAD)
- Real Decreto 175/2001, normas de correcta elaboración y control de calidad de fórmulas magistrales y preparados oficinales (texto consolidado), Boletín Oficial del Estado
- Preguntas y respuestas frecuentes sobre el Reglamento (CE) Nº 1223/2009 sobre los productos cosméticos, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
- Campaña contra la venta ilegal de medicamentos en Internet, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
- Alertas alimentarias de complementos alimenticios, Agencia Española de Seguridad Alimentaria y Nutrición (AESAN), Ministerio de Sanidad
General information, not legal advice. Rules change: check the official source before you act.